Drug Profile
QRS 5005
Latest Information Update: 30 Mar 2001
Price :
$50
*
At a glance
- Originator Groupe Fournier
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Septic shock
Most Recent Events
- 30 Mar 2001 Discontinued-Preclinical for Septic shock in Germany (Unknown route)
- 21 Oct 1997 Preclinical development for Septic shock in Germany (Unknown route)